Member Info for xviolet

If everyone else has failed and Synairgen is the last contender that is a very strange situation. It effects all kinds of odds and probabilities. It requires, for me, some thought.

or maybe just low volume - usually an RNS wakes people up, perhaps not this one.

Yeah I bought a little more today. The sp had a 'held down' feeling for me.

It is good the basic investment case is re-stated - even if it gets a little repetitive. For new investors coming in its good to read that. Just as sharing your skepticism is also good. I would think the current sp is pretty good (as in low-ish) if you want to come in.

Ruga

I don't think smoking weed impairs research skills - quite the opposite probably. Although it may depend on the type of weed. But if you had to write a report afterwards, then, I think, the weed would slow you down.

Ducati2

thanks for that. from davy smith as well...what he has to say right at the end (see below)...is very very interesting. really thank you so much for digging out that link/film.

"I don't know about anti-inflmamatorys early on. We're definitely looking at different agents for that. And I think some of the immume modulators like inhaled interferon might hit both - be an anti-viral and also change the inflammatory landscape."

Davey Smith is....protocal chair of the Activ-2 study in the US. Super sonic bigwig in Covid US research and policy.

Here he is talking about MABs. (very up to the minute video, I think)..30 minutes on MABs...in the closing seconds he talks about future therapies for Covid and mentions the Jak/Stat pathway. The whole interview is good or you can just skip to the last minute.

https://www.youtube.com/watch?v=rmcKUWd0wks

I have shares in Next Source Materials - graphite/vanadium mine - they did consolidation, it knocked the sp and sentiment for a while, for about 2 months- then massive, massive recovery. SAR seems to be on people's radar, lots of buys - people, I think are watching. I'm not going to risk selling into any dip to squeeze 10% or so more shares - but getting ready to buy if it slides.

yes. filtered and ignored.

btw i don't understand the science. I just buy 'em cheap, don't buy 2 many, and hope for the best.

ionq up again. possibly because of the following (they outperformed some IBM). One or two bits of good news and it could explode. It has form and sentiment for large, fast movement.

https://www.researchgate.net/publication/358219991_Experimental_QND_measurements_of_complementarity_on_two-qubit_states_with_IonQ_and_IBM_Q_quantum_computers

I'm just beginning to have a look at Scancell and HZM - just looking for a few comps that are low-ish on price and won't do much for 1-3 years so there's no rush and I can slowly build up a holding.

I will have to disappoint. I have not had time to have any thoughts on GGP. But I would follow John - who said it should return to the mid 20s - but I'm not investing in GGP...yet....I am waiting for EISB, SAR, HE1, IQAI and even Syn to produce returns - that could be weeks or months. But I guess GGP has the power of past sentiment - like HE1 - which could drive it hard.

Mr W...

Bit harsh, I think. But I do find some a little 2 excitable at times. I have been looking at the sp of Brii, for example. But...we shall see. Take care, stay chipper and all that.

OK. thanks guys
and no danger they were also referring to budesonide?

Couldn't the inhaled bit also refer to Gilead's nebulised Remdesivir?

Yes. The data must be complex. On my dumbass level, you get miracle cures. In the real world I guess its complex. I remember trying to read some of the protocols for ACVTIV - that was a painful afternoon for me. Personally I can't easily square the confidence of the Synairgen website with disastrous results. Beyond that I understand nothing.

Nolupus

Good to hear from you. And thank you.

I wish I knew the ways of pharma well enough to plot Synairgen. Like if a company gets a EUA are there still more trials and tests before some kind of full approval - like FDA approval etc?. I wonder if the longed for Synairgen RNS will be equivocal - good enough for a temporary roll-out in the US, where the health service is suffering - but not good enough for the share price they dream about on the BB. Or is good enough for EUA good enough for instant multi-bagger gold - by default?

Hi 1509

sorry about the delay. was socializing! and forgot. anyway....for february

EISB
Canterra Minerals Corp CTM
IQAI

thanks.